Related Experiment Video
Updated: Apr 28, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Peanut allergy
1Division of Allergy/Immunology, Wayne State University, and Pediatric Residency Program, The Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan 48201, USA. mpansare@dmc.org
Insights
Peanut allergy management is advancing, with oral immunotherapy showing promise for desensitization. Research also explores early introduction of peanut protein to build tolerance in infants.
Area of Science:
- Allergy and Immunology
- Pediatric Medicine
- Clinical Research
Background:
- Peanut allergy is increasingly prevalent in children, particularly in developed nations.
- The exact causes for the rising prevalence remain under investigation, with various environmental and specific factors hypothesized.
- Current management focuses on strict peanut avoidance and emergency treatment for anaphylaxis.
Purpose of the Study:
- To review and highlight recent breakthroughs in the clinical management of peanut allergy.
- To discuss emerging diagnostic tools and therapeutic strategies for peanut allergy.
Main Methods:
- Review of recent clinical trials and prospective studies on peanut allergy management.
- Analysis of data from studies investigating peanut oral immunotherapy (OIT).
- Examination of research on early dietary interventions, such as the LEAP study.
Main Results:
- Peanut oral immunotherapy (OIT) trials have demonstrated successful desensitization in participants.
- Ongoing studies are evaluating the impact of early high-dose peanut protein introduction versus avoidance in high-risk infants.
- Component-resolved diagnostics are being developed to better assess clinical sensitivity.
Conclusions:
- Currently, there is no definitive cure for peanut allergy.
- Peanut oral immunotherapy presents a viable therapeutic option for achieving desensitization.
- Further research into immunotherapeutic approaches is underway in both human and animal models.
Purpose Of Review:
To highlight recent advances in management of peanut allergy.
Recent Findings:
Peanut allergy presents during early childhood. The prevalence of peanut allergy in children in developed countries appears to be increasing. Several factors, such as peanut-specific or environmental, are hypothesized as contributing to increased prevalence. However, there is no consensus on this matter. Component-related diagnostic tests are being explored to characterize clinical sensitivity. Currently, the primary treatment includes avoidance of peanut and immediate treatment of anaphylaxis. Recent peanut oral immunotherapy (OIT) trials achieved successful desensitization to peanuts in study participants, which may benefit many patients. Newer prospective studies are exploring effects of early high-dose peanut protein introduction versus avoidance in high-risk infants and development of peanut tolerance [Learning Early About Peanut Allergy (LEAP) study]. Several other immunotherapeutic approaches are being investigated in animal models.
Summary:
There is no cure for peanut allergy. Peanut oral immunotherapy offers a potential treatment for desensitization.
Related Concept Videos
Cross-reactivity
Allergic Reactions
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions: Anaphylaxis

